The review “Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas” by Michael Wollring and colleagues discusses PET studies in glioma patients with an isocitrate dehydrogenase (IDH) gene mutation [12]. This evidence concerns the gene IDH2 and glioma.